Abstract:BACKGROUND: Colorectal cancer (CRC) is one of the most common tumors worldwide, with approximately 1 million new cases diagnosed in 2000, and accounting for over 500,000 deaths. Novel agents that target specific molecular pathways are needed. A replication-competent adenoviral transduction of manganese superoxide dismutase (MnSOD) inhibited growth of colorectal tumor cells in culture and tumor xenografts in a mouse model (Cancer Research; 2006 in press). Fluorouracil (5-FU) is the most widely used anticancer agent for gastrointestinal cancers, and it is commonly used as adjuvant chemotherapy for colorectal cancer. The aim of this study is to assess the effect of MnSOD gene therapy combined with chemotherapy, on tumor growth and tumor-free survival. METHODS: Nude mice were divided into four groups: PBS control, ZD55-MnSOD injection, 5-FU injection, combined ZD55-MnSOD with 5-FU injection. 5-FU was administered intraperitoneally every other day after four times injection with ZD55-MnSOD. Cell cycles were assayed by FACS. DNA fragmentation, transition electronic microscope and TUNEL assay were used to determine the extent of apoptosis. RESULTS: There was a remarkable decrease in cell viability after colorectal tumor cells were treated with ZD55- MnSOD at various MOI and 5-FU from 24 hours to 72 hours. Enhanced apoptosis in tumor cells receiving the dual therapy was evident as determined by DNA fragmentation analysis, Hoechst 33258 staining, electron microcopy, and a TUNEL assay. Growth of tumor xenografts was significantly inhibited in nude mice 2 months after intratumoral injection of ZD55-MnSOD. The tumor volume decreased significantly in mice after receiving combined injection of ZD55-MnSOD and 5-FU, was much lower than that in mice receiving injections of ZD55-MnSOD or 5-FU alone (80.98±31.76 vs. 792.11±69.70, 1050±435.39 mm3). Moreover, the combined injection of ZD55-MnSOD with 5-FU markedly improved the animal survival, which was better than ZD55-MnSOD or 5-FU alone (66.7% vs. 50% and 33.3%). CONCLUSION: Both ZD55- MnSOD and 5-FU are shown to induce the apoptosis in colorectal tumor cells, while 5-FU potentiated the proapoptotic effect induced by ZD55-MnSOD. It appears that a caspase-dependent pathway is involved in the apoptotic onset in colorectal tumor cells caused by 5-FU or ZD55-MnSOD. Thus, dual adenoviral MnSOD gene therapy plus 5-FU chemotherapy achieved synergetic action in suppressing the tumor growth.

Targeting Gene-Virus-mediated Manganese Superoxide Dismutase Effectively Suppresses Tumor Growth in Hepatocellular Carcinoma in Vitro and in Vivo.

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

Dual GSH-exhausting Sorafenib Loaded Manganese-Silica Nanodrugs for Inducing the Ferroptosis of Hepatocellular Carcinoma Cells.

Combined Use of Chemotherapeutics and Oncolytic Adenovirus in Treatment of AFP-expressing Hepatocellular Carcinoma

Complete Elimination Of Colorectal Tumor Xenograft By Combined Manganese Superoxide Dismutase With Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene Virotherapy

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

A Multifunctional Vanadium-Iron-Oxide Nanoparticle Eradicates Hepatocellular Carcinoma Via Targeting Tumor and Endothelial Cells

A New Oncolytic Adenoviral Vector Carrying Dual Tumour Suppressor Genes Shows Potent Anti-Tumour Effect

Synergistic Combination of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Oncolytic Adenovirus Zd55-Trail As A Therapy Against Cervical Cancer

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

Combined Treatment of Cholangiocarcinoma with Interventional Radiofrequency Hyperthermia and Heat Shock Protein Promoter-Mediated HSV-TK Gene Therapy.

Combination Effect of Oncolytic Adenovirus Therapy and Herpes Simplex Virus Thymidine Kinase/ganciclovir in Hepatic Carcinoma Animal Models.

Implication of Myeloid Differentiation Factor 88 Inhibitor TJ-M2010-5 for Therapeutic Intervention of Hepatocellular Carcinoma.

DNA Polymerases as targets for gene therapy of hepatocellular carcinoma

Oncolytic Adenovirus-Mediated E1A Gene Therapy Induces Tumor-Cell Apoptosis and Reduces Tumor Angiogenesis Leading to Inhibition of Hepatocellular Carcinoma Growth in Animal Model

A novel recombinant adenovirus expressing apoptin and melittin genes kills hepatocellular carcinoma cells and inhibits the growth of ectopic tumor

Adenovirus-Mediated Combined Anti-Angiogenic and Pro-Apoptotic Gene Therapy Enhances Antitumor Efficacy in Hepatocellular Carcinoma

Enhanced Inhibitory Effect and Mechanisms of Adenovirus-Mediated Hepatocellular Carcinoma Supressor Gene 1 Combined with 5-FU on Growth of LoVo Cells

Arsenite-loaded albumin nanoparticles for targeted synergistic chemo-photothermal therapy of HCC

833. Combined Manganese Superoxide Dismutase Gene Therapy and 5-FU Chemotherapy for Colorectal Cancer

Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo.